Merck's Keytruda Is First Checkpoint Inhibitor To Win US Approval Based On TMB Biomarker

 
• By Jessica Merrill
Athlete in action of high jump.
Keytruda clears a bar for use in TMB-high tumors • Source: Shutterstock

More from New Products

More from Scrip